Codexis (CDXS) Receivables - Net (2010 - 2026)
Codexis' (CDXS) quarterly Receivables - Net came in at $8.0 million in Q1 2026, down 30.72% year-on-year from $11.6 million in Q1 2025, and down 24.88% quarter-over-quarter from $10.7 million in Q4 2025.
Codexis (CDXS) Receivables - Net (2010 - 2026) Analysis & Trends
Codexis' Receivables - Net history runs 17 years deep, the most recent figure standing at $8.0 million for Q1 2026.
- On a quarterly basis, Receivables - Net fell 30.72% year-over-year to $8.0 million in Q1 2026; TTM through Mar 2026 was $8.0 million, a 30.72% decrease from a year earlier, with the FY2025 full-year figure at $10.7 million, down 43.41% from the prior year.
- Receivables - Net eased to $8.0 million in Q1 2026 per CDXS's latest filing, from $10.7 million in the prior quarter.
- Across five years, Receivables - Net topped out at $48.9 million in Q2 2022 and bottomed at $6.2 million in Q1 2024.
- The 5-year median for Receivables - Net is $12.4 million (2024), against an average of $16.9 million.
- Across the five-year window, Receivables - Net soared 151.03% in 2022 and sank 82.0% in 2023, its largest moves.
- Year by year, Receivables - Net stood at $31.9 million in 2022, then tumbled by 37.54% to $19.9 million in 2023, then fell by 5.24% to $18.9 million in 2024, then slumped by 43.41% to $10.7 million in 2025, then dropped by 24.88% to $8.0 million in 2026.
- Per Business Quant, the three latest CDXS Receivables - Net figures stand at $8.0 million (Q1 2026), $10.7 million (Q4 2025), and $9.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Codexis | 180.63 Mn | 115.49 Mn | 13.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.03 Mn |
| Mar 31, 2026 | 8.03 Mn |
| Dec 31, 2025 | 10.69 Mn |
| Dec 31, 2025 | 10.69 Mn |
| Sep 30, 2025 | 9.73 Mn |
| Sep 30, 2025 | 9.73 Mn |
| Jun 30, 2025 | 12.27 Mn |
| Jun 30, 2025 | 12.27 Mn |
| Mar 31, 2025 | 11.59 Mn |
| Mar 31, 2025 | 11.59 Mn |
| Dec 31, 2024 | 18.88 Mn |
| Dec 31, 2024 | 18.88 Mn |
| Sep 30, 2024 | 16.54 Mn |
| Sep 30, 2024 | 16.54 Mn |
| Jun 30, 2024 | 12.39 Mn |
| Jun 30, 2024 | 12.39 Mn |
| Mar 31, 2024 | 6.24 Mn |
| Mar 31, 2024 | 6.24 Mn |
| Dec 31, 2023 | 19.93 Mn |
| Dec 31, 2023 | 19.93 Mn |